Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized placebo-controlled study of DermaVir (LC002) patch in treatment-naive HIV-1-infected patients
2007-001955-20Phase 2Completed
- Sponsor
- Genetic Immunity
- Start
- Aug 2007
- Modality
- Vaccines & Immunotherapeutics, DNA Therapeutics → Nucleic Acid Therapeutics, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised trial in human immunodeficiency virus infection (HIV) comparing DermaVir patch with Placebo patch (2 arms). Started Aug 2007; status: completed.
02
Drugs
DermaVir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2007-001955-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001955-20.